Another overdose reversal drug reaches the market
Opvee is an inhaled version of nalmefene, a drug approved nearly 30 years ago in injectable and oral forms to reverse opioid overdoses.
Source: politico.com
📰 Shortages Prevention Program News
Shortages Prevention Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Shortages Prevention Program. Real-time updates on events, politics, business and more.
Global Healthcare Industry ESG (Environmental, Social, and Governance) Trends Report 2023: Focus on Healthcare Equipment Providers, Biotech Companies, and Life Sciences Tools and Services Companies
/PRNewswire/ -- The "ESG Trends in the Healthcare Industry" report has been added to ResearchAndMarkets.coms offering. The aim of this study is to evaluate...
Laura Wood E St Office Hours Call Shortages Prevention Program Rscspp Office Hours Call Impact Of Climate Change On Human Health Nhs To Deliver Net Zero Health Service
Source: prnewswire.com
4 Key Considerations For Onshoring Inbound Medtech Supply Chains
Many medtech supply chains hold a significant amount of redundant inventory, from orthopedic spare parts to unutilized loose instruments. If the...
Source: meddeviceonline.com